Pennant Group Beheer

Beheer criteriumcontroles 4/4

De CEO Pennant Group is Brent Guerisoli, benoemd in Aug2022, heeft een ambtstermijn van 2.25 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 1.87M, bestaande uit 19.4% salaris en 80.6% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 0.24% van de aandelen van het bedrijf, ter waarde $ 2.50M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 2 jaar en 5.5 jaar.

Belangrijke informatie

Brent Guerisoli

Algemeen directeur

US$1.9m

Totale compensatie

Percentage CEO-salaris	19.4%
Dienstverband CEO	2.3yrs
Eigendom CEO	0.2%
Management gemiddelde ambtstermijn	2yrs
Gemiddelde ambtstermijn bestuur	5.5yrs

Recente managementupdates

Recent updates

Investors Shouldn't Be Too Comfortable With Pennant Group's (NASDAQ:PNTG) Earnings

Nov 14

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 34% Discount?

Nov 12

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

Oct 06

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Sep 14

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Dec 25

Pennant Group (NASDAQ:PNTG) Is Reinvesting At Lower Rates Of Return

Sep 02

Pennant acquires California-based Ardent Hospice and Palliative Care

Aug 16

Pennant Non-GAAP EPS of $0.14 in-line, revenue of $116.3M beats by $4.02M

Aug 08

Analyse CEO-vergoeding

Hoe is Brent Guerisoli's beloning veranderd ten opzichte van Pennant Group's winst?
Datum	Totale vergoeding	Salaris	Bedrijfswinsten
Sep 30 2024	n/a	n/a	US$21m
Jun 30 2024	n/a	n/a	US$19m
Mar 31 2024	n/a	n/a	US$16m
Dec 31 2023	US$2m	US$363k	US$13m
Sep 30 2023	n/a	n/a	US$13m
Jun 30 2023	n/a	n/a	US$13m
Mar 31 2023	n/a	n/a	US$7m
Dec 31 2022	US$2m	US$296k	US$7m
Sep 30 2022	n/a	n/a	US$1m
Jun 30 2022	n/a	n/a	-US$3m
Mar 31 2022	n/a	n/a	US$3m
Dec 31 2021	US$760k	US$268k	US$3m
Sep 30 2021	n/a	n/a	US$9m
Jun 30 2021	n/a	n/a	US$12m
Mar 31 2021	n/a	n/a	US$14m
Dec 31 2020	US$2m	US$228k	US$16m
Sep 30 2020	n/a	n/a	US$8m
Jun 30 2020	n/a	n/a	US$5m
Mar 31 2020	n/a	n/a	US$4m
Dec 31 2019	US$605k	US$55k	US$3m

Compensatie versus markt: De totale vergoeding ($USD 1.87M ) Brent } ligt onder het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.20M ).

Compensatie versus inkomsten: De vergoeding van Brent is het afgelopen jaar in lijn geweest met de bedrijfsprestaties.

CEO

Brent Guerisoli (43 yo)

2.3yrs

Tenure

US$1,868,520

Compensatie

Mr. Brent J. Guerisoli has been Chief Executive Officer of The Pennant Group, Inc. since August 01, 2022, serves as its Director since February 28, 2023 and served as its President since January 1, 2021 un...

Leiderschapsteam

Naam	Positie	Tenure	Compensatie	Eigendom
Brent Guerisoli	CEO & Director	2.3yrs	US$1.87m	0.24% $ 2.5m
John Gochnour	President & COO	5.8yrs	US$1.50m	0.36% $ 3.8m
Lynette Walbom	Chief Financial Officer	1.5yrs	US$946.99k	0% $ 0
Kirk Cheney	General Counsel & Corporate Secretary	1.8yrs	US$713.05k	geen gegevens
Jason Steik	Chief Clinical Officer	no data	US$721.00k	0% $ 0
Brian Wayment	President of Cornerstone Healthcare	no data	geen gegevens	0% $ 0

2.0yrs

Gemiddelde duur

43yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PNTG wordt beschouwd als ervaren (gemiddelde ambtstermijn 2 jaar).

Bestuursleden

Naam	Positie	Tenure	Compensatie	Eigendom
Brent Guerisoli	CEO & Director	1.8yrs	US$1.87m	0.24% $ 2.5m
Barry Smith	Independent Chairman	3.6yrs	US$335.43k	0.20% $ 2.1m
Scott Lamb	Independent Director	5.8yrs	US$169.32k	0.12% $ 1.3m
John Nackel	Independent Director	5.1yrs	US$166.32k	0.48% $ 5.0m
Jo Stringfield	Independent Director	5.8yrs	US$176.82k	0.081% $ 855.8k
Christopher Christensen	Non-Independent Director	5.8yrs	US$143.82k	2.2% $ 23.3m
Stephen M. Covey	Independent Director	5.8yrs	US$149.32k	0.090% $ 946.4k
Gregory Morris	Independent Director	2.8yrs	US$147.82k	0.070% $ 738.7k

5.5yrs

Gemiddelde duur

63yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PNTG wordt beschouwd als ervaren (gemiddelde ambtstermijn 5.5 jaar).

Pennant Group Beheer

Beheer criteriumcontroles 4/4

Belangrijke informatie

Recente managementupdates

CEO & Director notifies of intention to sell stock

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Independent Chairman recently bought US$67k worth of stock

Recent updates

Investors Shouldn't Be Too Comfortable With Pennant Group's (NASDAQ:PNTG) Earnings

Is The Pennant Group, Inc. (NASDAQ:PNTG) Trading At A 34% Discount?

Third quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

Price target increased by 12% to US$37.50

The Pennant Group, Inc. to Report Q3, 2024 Results on Nov 06, 2024

Price target increased by 9.5% to US$34.50

Is Now The Time To Put Pennant Group (NASDAQ:PNTG) On Your Watchlist?

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

New minor risk - Shareholder dilution

The Pennant Group, Inc. has completed a Follow-on Equity Offering in the amount of $108.5 million.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

The Pennant Group, Inc. has filed a Follow-on Equity Offering.

Now 21% undervalued

Price target increased by 12% to US$33.50

Investors Still Waiting For A Pull Back In The Pennant Group, Inc. (NASDAQ:PNTG)

Now 21% undervalued

Does Pennant Group (NASDAQ:PNTG) Have A Healthy Balance Sheet?

Second quarter 2024 earnings: Revenues exceed analysts expectations while EPS lags behind

Now 20% undervalued

The Pennant Group, Inc. Updates Earnings Guidance for the Year 2024

CEO & Director notifies of intention to sell stock

The Pennant Group, Inc. to Report Q2, 2024 Results on Aug 06, 2024

Price target increased by 7.8% to US$27.50

Independent Director exercised options to buy US$1.3m worth of stock.

The Pennant Group, Inc. acquired Nurses On Wheels, Inc.

Now 21% undervalued

Here's Why Pennant Group (NASDAQ:PNTG) Can Manage Its Debt Responsibly

Price target increased by 13% to US$24.75

First quarter 2024 earnings: EPS and revenues exceed analyst expectations

The Pennant Group, Inc. (NasdaqGS : PNTG) acquired South Davis Community Hospital, Inc.

The Pennant Group, Inc. to Report Q1, 2024 Results on May 06, 2024

New minor risk - Shareholder dilution

The Pennant Group, Inc., Annual General Meeting, May 23, 2024

President & COO exercised options to buy US$214k worth of stock.

The Pennant Group, Inc. (NASDAQ:PNTG) Not Flying Under The Radar

Price target increased by 22% to US$19.50

Full year 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. Provides Revenue Guidance for 2024

The Pennant Group, Inc. to Report Q4, 2023 Results on Feb 28, 2024

Pennant Group (NASDAQ:PNTG) Takes On Some Risk With Its Use Of Debt

Price target increased by 10% to US$16.00

Third quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

the Pennant Group, Inc. Provides Earnings Guidance for the Year 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Guardian Hospice of Texas and Guardian Hospice of Oklahoma.

The Pennant Group, Inc. to Report Q3, 2023 Results on Nov 07, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Valor HospiceCare.

Price target decreased by 7.1% to US$14.25

Second quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q2, 2023 Results on Aug 08, 2023

The Pennant Group, Inc. (NasdaqGS:PNTG) acquired Bluebird Home Health, Bluebird Hospice, and Bluebird Home Care.

Price target decreased by 8.5% to US$15.33

The Pennant Group, Inc. Announces Jennifer Freeman Assume the Role of Senior Vice President of Strategic Partnerships

Investor sentiment deteriorates as stock falls 18%

The Pennant Group, Inc. acquired Assets Of Benefit Health Care.

The Returns On Capital At Pennant Group (NASDAQ:PNTG) Don't Inspire Confidence

First quarter 2023 earnings: Revenues exceed analysts expectations while EPS lags behind

Investor sentiment improves as stock rises 16%

Independent Chairman recently bought US$67k worth of stock

Investor sentiment improves as stock rises 20%

Is Pennant Group (NASDAQ:PNTG) A Risky Investment?

Full year 2022 earnings: Revenues exceed analysts expectations while EPS lags behind

The Pennant Group, Inc. to Report Q4, 2022 Results on Feb 23, 2023

Investors Could Be Concerned With Pennant Group's (NASDAQ:PNTG) Returns On Capital

Consensus forecasts updated

The Pennant Group, Inc. (NasdaqGS:PNTG) announces an Equity Buyback for $1 million worth of its shares.

Independent Director recently bought US$203k worth of stock

Consensus forecasts updated

Consensus forecasts updated